Chrysalyne D. Schmults, MD, MSCE, Director, Mohs and Dermatologic Surgery Center at Brigham and Women’s Hospital and Director, High-Risk Skin Cancer Clinic at Dana Farber/Brigham and Women’s Cancer Center discusses the prevalence of non-melanoma (basal cell and squamous cell) skin cancer and treatment options for patients, including Mohs surgery.
Mohs surgery, a form of skin cancer removal in which the borders are examined by the surgeon microscopically while the patient waits, boasts a remarkable 99% cure rate for most basal and squamous cell skin cancers as well as a high cure rate for other rare forms of skin cancer. Since very little normal tissue is removed during the treatment, our surgeons are able to reconstruct most wounds with excellent cosmetic results. When surgical removal is not necessary, our Center also offers cream and other topical treatments for superficial skin cancers.
Our Mohs Dermatologic Surgery Center located at Brigham and Women’s Faulkner Hospital offers highly specialized outpatient treatment of skin cancer with excellent outcomes.
Learn more at: [ Ссылка ]
